MedPath
FDA Approval

Amethyst

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Actavis Pharma, Inc.
DUNS: 119723554
Effective Date
December 31, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ethinylestradiol(20 ug in 1 1)
Levonorgestrel(90 ug in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Amethyst

Product Details

NDC Product Code
52544-295
Application Number
ANDA079218
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 31, 2021
Code: 423D2T571UClass: ACTIBQuantity: 20 ug in 1 1
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
Code: 5W7SIA7YZWClass: ACTIBQuantity: 90 ug in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
© Copyright 2025. All Rights Reserved by MedPath